Clinical Trials · NCT03130426
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Population Health Research Institute
- Enrollment
- 161
- Start date
- Jun 2017
- Locations
- 8 sites, Canada
- Primary endpoint
- The first occurrence of diabetes relapse